Berberine phospholipid exerts a positive effect on the glycemic profile of overweight subjects with impaired fasting blood glucose (IFG): a randomized double-blind placebo-controlled clinical trial.

内科学 内分泌学 医学 血糖性 糖化血红素 安慰剂 血脂谱 载脂蛋白B 空腹血糖受损 超重 胆固醇 糖尿病 血脂 2型糖尿病 胰岛素 糖耐量受损 肥胖 替代医学 病理
作者
Mariangela Rondanelli,Clara Gasparri,Giovanna Petrangolini,Pietro Allegrini,Daniele Avenoso,Teresa Fazia,Luisa Bernardinelli,Gabriella Peroni,Zaira Patelli,Francesca Mansueto,Alice Tartara,Alessandro Cavioni,Antonella Riva
出处
期刊:PubMed 卷期号:27 (14): 6718-6727 被引量:5
标识
DOI:10.26355/eurrev_202307_33142
摘要

Berberine is a plant alkaloid known to exert positive metabolic effects. Human studies have confirmed its ability to improve the lipid and glycemic profile. This study aimed to evaluate the potential benefit of oral supplementation of Berberine PhytosomeTM (2 tablets/day, 550 mg/tablet) on the metabolic profile of subjects with impaired fasting blood glucose (IFG).A total of 49 overweight subjects, 28 females and 21 males, were randomly assigned to either the supplemented group (n=24) or placebo (n=25). We considered glycemia as the primary endpoint and total cholesterol, high-density lipoprotein (HDL), total cholesterol/HLD, low-density lipoprotein (LDL), LDL/HDL, triglycerides, insulin, glycated hemoglobin, Homeostasis Model Assessment (HOMA), ApoA, ApoB, ApoB/ApoA, androgen suppression treatment (AST), alternative lengthening of telomeres (ALT), gamma-glutamyl transferase (GGT), creatinine, and body composition by dual-energy X-ray absorptiometry (DXA) as secondary endpoints. These parameters have been assessed at baseline, after 30 days, and after 60 days.After two months of treatment, through the use of linear mixed effect models, a statistically significant difference between supplemented and placebo groups was observed for glycemia [β=-0.2495% C.I. (-0.47; -0.06), p=0.004], total cholesterol [β=-0.25, 95% C.I. (-0.45; -0.04), p=0.05], total cholesterol/HDL [β=-0.25, 95% C.I. (-0.43; -0.06), p=0.04], triglycerides [β=-0.14, 95% C.I. (-0.25; -0.02), p=0.05], insulin [β=-1.78, 95% C.I. (-2.87; -0.66), p=0.009], ApoB/ApoA [β=-0.08, 95% C.I. (-0.13; -03), p=0.004], Visceral adipose tissue (VAT) [β=-91.50, 95% C.I. (-132.60; -48.19), p<0.0001] and fat mass [β=-945.56, 95% C.I. (-1,424.42; -441.57), p=0.004].The use of berberine had no adverse events, supporting its use as a natural alternative to pharmacological therapies in the case of IFG.

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
彳亍发布了新的文献求助10
1秒前
2秒前
4秒前
燕小冷发布了新的文献求助10
4秒前
科研通AI6应助fanfanqieqie采纳,获得10
5秒前
6秒前
勤劳的俊驰应助FG采纳,获得10
6秒前
9秒前
紧张的冥应助gy79210采纳,获得10
10秒前
Owen应助微垣采纳,获得10
10秒前
12秒前
13秒前
crf912发布了新的文献求助10
14秒前
剑南节度使完成签到,获得积分10
14秒前
SciGPT应助左丘世立采纳,获得10
14秒前
xiazhq发布了新的文献求助100
14秒前
15秒前
ionicliquids发布了新的文献求助10
15秒前
希望天下0贩的0应助shine采纳,获得10
15秒前
Bizi完成签到,获得积分10
16秒前
16秒前
啊哦呃发布了新的文献求助10
16秒前
18秒前
英姑应助xiaoxing采纳,获得10
18秒前
19秒前
自然醒完成签到 ,获得积分10
20秒前
量子星尘发布了新的文献求助20
21秒前
今后应助李欣采纳,获得10
22秒前
xxl发布了新的文献求助20
23秒前
23秒前
贝贝贝发布了新的文献求助10
24秒前
庄卞伟完成签到,获得积分10
24秒前
29秒前
汉堡包应助Ray采纳,获得10
30秒前
30秒前
30秒前
30秒前
31秒前
31秒前
31秒前
高分求助中
(应助此贴封号)【重要!!请各位详细阅读】【科研通的精品贴汇总】 10000
Organic Chemistry 1500
Bulletin de la Societe Chimique de France 400
Assessment of adverse effects of Alzheimer's disease medications: Analysis of notifications to Regional Pharmacovigilance Centers in Northwest France 400
Introducing Sociology Using the Stuff of Everyday Life 400
Conjugated Polymers: Synthesis & Design 400
Picture Books with Same-sex Parented Families: Unintentional Censorship 380
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 遗传学 基因 物理化学 催化作用 冶金 细胞生物学 免疫学
热门帖子
关注 科研通微信公众号,转发送积分 4277392
求助须知:如何正确求助?哪些是违规求助? 3806160
关于积分的说明 11925222
捐赠科研通 3452862
什么是DOI,文献DOI怎么找? 1893697
邀请新用户注册赠送积分活动 943733
科研通“疑难数据库(出版商)”最低求助积分说明 847537